In 2001, Vertex Pharmaceuticals has acquired United San Diego biotech company, Aurora Biosciences. The combination of Vertex and Technology Aurora would improve the flow of new drug candidates in development. However, some issues related to the integration in Aurora Vertex has not been resolved, the most relevant are major collaboration with Aurora CF Foundation (CFF). Were venture philanthropy and foundation deals appropriate funding mechanism for public companies like Vertex? How could the Board of Vertex and CFF fundamentally agree on the objectives of a commercial company with the non-profit organization? These were the questions faced by managers Vertex. "Hide
by Robert F. Higgins, Brent Kazan Source: Harvard Business School 27 pages. Publication Date: October 15, 2007. Prod. #: 808005-PDF-ENG
Related Case Solutions & Analyses:
Harley-Davidson: Preparing for the Next Century
Leadership Development at Goldman Sachs
Sapientis and the Launch of CECE
InvestCo: Ranking and Promotion Redesign
NESWC (B)
Cerner Corp. (B)
Trilogy (A)
Passive Activity Losses
Viña San Pedro (VSP)
Crown Worldwide: Integrating Corporate Social Responsibility in Business
